Lv72
3670 积分 2024-07-26 加入
Stress it up
10天前
已完结
Akt Inhibitor Advancements: From Capivasertib Approval to Covalent-Allosteric Promises
12天前
已完结
Delivering on the promise of protein degraders
2个月前
已完结
Molecular glue degraders: exciting opportunities for novel drug discovery
2个月前
已完结
The European Federation for Medicinal Chemistry and Chemical Biology (EFMC) Best Practice Initiative: Hit to Lead
2个月前
已完结
MYC in cancer: from undruggable target to clinical trials
2个月前
已完结
Discovery and Structure-Based Design of Inhibitors of the WD Repeat-Containing Protein 5 (WDR5)–MYC Interaction
2个月前
已完结
Rational Design and Systemic Appraisal of an EGFR-Targeting Antibody–Drug Conjugate LR-DM1 for Pancreatic Cancer
2个月前
已完结
Antibody drug conjugates beyond cytotoxic payloads
2个月前
已完结
The medicinal chemistry evolution of antibody–drug conjugates
2个月前
已完结
皖公网安备34019202002308
